UAB "Vivere Pharmaceutica" Finance - revenue, profit
EBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo dataIndicator |
---|
Turnover (€) |
Sales per employee (€) |
Profit before tax (€) |
Net Profit (€) |
Profit per employee (€) |
Total profitability (%) |
Net profitability (%) |
Equity (€) |
Amounts Payable And Liabilities (€) |
Non-current Assets (€) |
CurrentAssets (€) |
Working capital requirement |
Debt-to-equity ratio |
EBITDA margin (%) |
EBITDA (€) |
EBIT margin (%) |
EBIT (€) |
2022 |
---|
543,887 |
271,944 |
30,165 |
25,571 |
12,786 |
17.38 |
4.70 |
175,357 |
77,994 |
14,738 |
238,379 |
2023 |
---|
403,023 |
171,499 |
51,411 |
43,695 |
18,594 |
23.65 |
10.84 |
100,229 |
13,225 |
10,083 |
101,886 |
2024 |
---|
111,574 |
37,191 |
16,680 |
14,183 |
4,728 |
22.59 |
12.71 |
114,412 |
2,545 |
302 |
116,655 |
Register and
explore Okredo dataRegister and
explore Okredo data2024
Turnover (€)
111,574 €-72 % *
Sales per employee (€)
37,191 €-78 % *
Profit before tax (€)
16,680 €-68 % *
Net Profit (€)
14,183 €-68 % *
Profit per employee (€)
4,728 €-75 % *
Total profitability (%)
22.59 %-4.48 % *
Net profitability (%)
12.71 %17.25 % *
Equity (€)
114,412 €14 % *
Amounts Payable And Liabilities (€)
2,545 €-81 % *
Non-current Assets (€)
302 €-97 % *
CurrentAssets (€)
116,655 €15 % *